{"id":"W1990643914","doi":"10.1159/000200800","title":"Health-Related Quality of Life in Patients with Hormone Refractory Prostate Cancer Receiving Gefitinib","year":2009,"lang":"en","type":"article","venue":"Urologia Internationalis","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gefitinib; Prostate cancer; Quality of life (healthcare); Antiandrogen; Internal medicine; Oncology; Prostate-specific antigen; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003682812,0.0001136056,0.0003414438,0.0001712874,0.00002766982,0.000007417217,0.00008808661,0.00006534855,0.0001475292],"category_scores_gemma":[0.0002227795,0.00008029085,0.00004055497,0.0002196888,0.00007272096,0.0001009279,0.00002039636,0.0002384988,0.000004419439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002759608,"about_ca_system_score_gemma":0.0002673561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002027206,"about_ca_topic_score_gemma":0.0001434626,"domain_scores_codex":[0.9984761,0.00009456262,0.0005111775,0.0002306727,0.0004574705,0.0002300323],"domain_scores_gemma":[0.9990969,0.00007651465,0.0002809847,0.0001493812,0.0002924227,0.0001037938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00438523,0.0005784523,0.9821379,0.00003116676,0.00009783434,0.000006454901,0.0004596193,0.00003573293,0.0001598684,0.0001287578,0.0008947171,0.01108423],"study_design_scores_gemma":[0.005827785,0.001604303,0.9917968,0.00009905529,0.000007305268,6.157843e-7,0.00001928738,0.00002825936,0.00004446776,0.0001300131,0.0003675761,0.00007455057],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870083,0.002229247,0.000003381916,0.009085669,0.00005388985,0.0005187212,0.00009092617,0.00003031514,0.0009795958],"genre_scores_gemma":[0.9974666,0.0006464901,0.0001014122,0.0008902262,0.00002341669,0.00003346196,0.0002493702,0.000009876298,0.0005791556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01100968,"threshold_uncertainty_score":0.3274166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03388270765459418,"score_gpt":0.3426279617188834,"score_spread":0.3087452540642893,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}